Platinum Industries launches Rivadu Lifesciences to enter pharmaceutical innovation
Platinum Industries Ltd., a specialty chemicals company with a global footprint, is expanding into the life sciences sector. The move comes as the firm establishes Rivadu Lifesciences Pvt. Ltd., a new enterprise focused on high-value pharmaceutical innovation. To lead this venture, the company has appointed Dr. Abhigyan Upadhyay, a veteran with over 25 years of experience in the field. Platinum Industries has long served customers in over 30 countries, specialising in chemicals for plastics, paints, and coatings. Now, the company is shifting its focus toward life sciences, targeting research-driven areas like active pharmaceutical ingredients (APIs) and intermediates.
The expansion aligns with broader trends in the pharmaceutical industry, where supply chains are evolving and India is becoming a key player in innovation-led life sciences. Dr. Upadhyay, the newly appointed leader of Rivadu Lifesciences, brings expertise in regulated manufacturing, diagnostics, and research environments. Platinum Industries plans to build a scalable life sciences model by working with strategic partners. The company will rely on its strengths in execution and market access to create a disciplined, research-focused business with global reach.
The new life sciences division will initially concentrate on APIs and intermediates. With Dr. Upadhyay at the helm, Platinum Industries aims to establish a strong, innovation-driven presence in the sector. The company’s existing global network and operational expertise are expected to support its growth in this area.
